Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRAIN SCIENTIFIC INC.BRSF · Entity 124256 | 10% owner | June 15, 2022 | August 04, 2022 |
| Modular Medical, Inc.MODD · Entity 7488 | Director · 10% owner | September 30, 2026 | October 01, 2026 |
| NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808 | 10% owner | January 15, 2021 | January 21, 2021 |
| SANUWAVE Health, Inc.SNVW · Entity 7321 | Director · Chief Executive Officer | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRAIN SCIENTIFIC INC.
Report date June 15, 2022 · Filed August 04, 2022
Jointly reported with MANCHESTER MANAGEMENT CO LLC, MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P., JEB Partners, L.P., BESSER JAMES E
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | IndirectSee Footnote | 19,545,187 |
Reported balance
Holding disclosure · report date 2022-06-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 19,545,187 F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common Stock, $0.001 par valueSEC Table I · non-derivative | IndirectSee Footnote | 12,816,831 |
Reported balance
Holding disclosure · report date 2022-06-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,816,831 F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 8,028,706 |
Reported balance
Holding disclosure · report date 2022-06-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,028,706 F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2022-06-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2022-06-15 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.25 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-06-15 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F4: The reported warrants are exercisable as of the issue date, subject to certain conditions. F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions. F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity. |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2031-10-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-06-15 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference. F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2: The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3: The reported securities and warrants are directly owned by James E. Besser in his personal capacity.
F4: The reported warrants are exercisable as of the issue date, subject to certain conditions.
F5: The reported warrants expire at 5:00pm E.D.T. on the fourth anniversary of the issue date, subject to certain conditions.
F6: The reported warrants are subject to a blocker provision that prevents James E. Besser from exercising the warrants if he would be more than a 4.99% beneficial owner of the Common Stock, $0.001 par value, following such exercise. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Common Stock Purchase Warrant included as Exhibit 4.1 of the Issuer's 8-K filed on October 7, 2021, which is incorporated by reference.
Modular Medical, Inc.
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-09-30 | Direct | 62 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 62 · Balance 62 F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." |
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-09-30 | Direct | 312 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Grant · Acquired 250 · Balance 312 F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." |
Filing footnotes · ownership attribution and instrument terms
F1: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.
F2: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date January 15, 2021 · Filed January 21, 2021
Jointly reported with BESSER JAMES E, MANCHESTER MANAGEMENT CO LLC, MANCHESTER MANAGEMENT PR, LLC, Manchester Explorer, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 492,951 |
Reported balance
Holding disclosure · report date 2021-01-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 492,951 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 4,750,000 |
Reported balance
Holding disclosure · report date 2021-01-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,750,000 F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC. F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-15 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2026-01-15 | IndirectSee Footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC. F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities and warrants are directly owned by Manchester Explorer, L.P. JEB Partners, L.P and by Morgan C. Frank in his personal capacity. The reported securities and warrants are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester Management Company, LLC.
F2: The Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
SANUWAVE Health, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.71 · Expires 2031-09-30 | Direct | 11,286 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 11,286 · Balance 11,286 F1: Options were fully vested at the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options were fully vested at the grant date.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FENNEC PHARMACEUTICALS INC.
Report date January 27, 2016 · Filed March 29, 2018
Jointly reported with MANCHESTER MANAGEMENT PR, LLC, MANCHESTER MANAGEMENT CO LLC, Manchester Explorer, L.P., BESSER JAMES E
Section 16 reporting ended · disclosed 2018-03-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,666,666 |
Last balance in matching sequence
After 2018-03-28 transaction · row 24
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
15 source rowsRow 1 · 2018-03-08 · Sale · Disposed 10,000 · Balance 2,146,797 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 2 · 2018-03-12 · Sale · Disposed 18,560 · Balance 2,128,237 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 3 · 2018-03-13 · Sale · Disposed 16,934 · Balance 2,111,303 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 4 · 2018-03-14 · Sale · Disposed 13,600 · Balance 2,097,703 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 5 · 2018-03-16 · Sale · Disposed 6,423 · Balance 2,091,280 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 6 · 2018-03-16 · Sale · Disposed 2,120 · Balance 2,089,160 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 8 · 2018-03-19 · Sale · Disposed 200 · Balance 2,088,960 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 10 · 2018-03-20 · Sale · Disposed 4,200 · Balance 2,084,760 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 12 · 2018-03-20 · Sale · Disposed 15,183 · Balance 2,069,577 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 14 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,859,266 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 16 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,839,266 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 18 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,835,766 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 20 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,813,059 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 22 · 2018-03-28 · Sale · Disposed 605 · Balance 1,812,454 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Row 24 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,666,666 F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 1,250,000 |
Last balance in matching sequence
After 2018-03-28 transaction · row 25
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
10 source rowsRow 7 · 2018-03-16 · Sale · Disposed 2,120 · Balance 1,672,494 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 9 · 2018-03-19 · Sale · Disposed 200 · Balance 1,672,294 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 11 · 2018-03-20 · Sale · Disposed 4,200 · Balance 1,668,094 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 13 · 2018-03-20 · Sale · Disposed 15,183 · Balance 1,652,911 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 15 · 2018-03-21 · Sale · Disposed 210,311 · Balance 1,442,600 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 17 · 2018-03-22 · Sale · Disposed 20,000 · Balance 1,422,600 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 19 · 2018-03-23 · Sale · Disposed 3,500 · Balance 1,419,100 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 21 · 2018-03-27 · Sale · Disposed 22,707 · Balance 1,396,393 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 23 · 2018-03-28 · Sale · Disposed 605 · Balance 1,395,788 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Row 25 · 2018-03-28 · Sale · Disposed 145,788 · Balance 1,250,000 F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. |
Filing footnotes · ownership attribution and instrument terms
F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC.
F2: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.
FiEE, Inc.
Report date August 03, 2020 · Filed August 05, 2020
Jointly reported with MANCHESTER MANAGEMENT CO LLC, Manchester Explorer, L.P., BESSER JAMES E
Section 16 reporting ended · disclosed 2020-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-08-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-08-03 · Sale · Disposed 4,287,214 · Balance 0 F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-08-03 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-08-03 · Sale · Disposed 2,857,643 · Balance 0 F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-08-03 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-08-03 · Sale · Disposed 143,357 · Balance 0 F3: The reported securities are directly owned by James E. Besser in his personal capacity. |
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-08-03 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-08-03 · Sale · Disposed 142,857 · Balance 0 F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity. |
Filing footnotes · ownership attribution and instrument terms
F1: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership.
F3: The reported securities are directly owned by James E. Besser in his personal capacity.
F4: The reported securities are directly owned by Morgan C. Frank in his personal capacity.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 3, 2022 18:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 1,875 | $4.34 Strike: $4.34 | $8,137.50 |
DisclosureSEC source: 0001019056-22-000612 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires 2032-09-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| July 19, 2022 Filed Aug 8, 2022 20:19 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 7,500 | $5.16 Strike: $5.16 | $38,700.00 |
DisclosureSEC source: 0001019056-22-000542 · frank.xml · derivative · entry 2 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-07-19 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| June 30, 2022 Filed Aug 8, 2022 20:19 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 3,634 | $5.16 Strike: $5.16 | $18,751.44 |
DisclosureSEC source: 0001019056-22-000542 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,634 Underlying: Common Stock · 3,634 shares Expires 2032-06-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:01 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 17,943 | $4.18 Strike: $4.18 | $75,001.74 |
DisclosureSEC source: 0001019056-22-000312 · frank.xml · derivative · entry 2 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,943 Underlying: Common Stock · 17,943 shares Expires 2032-03-31 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,325 shares of the Issuer. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:01 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 4,486 | $4.18 Strike: $4.18 | $18,751.48 |
DisclosureSEC source: 0001019056-22-000312 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,486 Underlying: Common Stock · 4,486 shares Expires 2032-03-31 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 90,325 shares of the Issuer. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | Exercise / conversionCommon Stock Purchase Warrant · Derivative | 234,274 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0000919574-22-001710 · ownership.xml · derivative · entry 6 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 234,274 Underlying: Common Stock, par value $0.001 per share · 234,274 shares Expires 2027-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | Exercise / conversionConvertible Promissory Note · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000919574-22-001710 · ownership.xml · derivative · entry 5 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 per share; Warrant · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · derivative.exercise_date: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · derivative.expiration_date: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · derivative.underlying_shares: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 23:54 UTC | Modular Medical, Inc. MODD · Entity 7488 | Exercise / conversionCommon Stock, par value $0.001 per share | 234,274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000919574-22-001710 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 2,218,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The reported securities were obtained due to the conversion of a Convertible Promissory Note (the "Note"). The Note was convertible into an equal amounts of shares of Common Stock, par value $0.001 per share and Common Stock Purchase Warrants at a conversion price equal to the sum of principal and accrued interest multiplied by 1.25. The principal amount of the Note was $1,026,630 and the Note had accrued $97,881 of interest. The total principal and interest was then multiplied by 1.25 resulting in a conversion value of $1,405,639. This translated to 234,274 shares of Common Stock, par value $0.001 per share and 234,274 Common Stock Purchase Warrants based upon a $6.00 purchase price. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:15 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock Purchase Warrant · Derivative | 300,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0000919574-22-001656 · ownership.xml · derivative · entry 5 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 300,000 Underlying: Common Stock, par value $0.001 per share · 300,000 shares Expires 2027-02-10 F1 · price: Manchester Management Company, LLC ("Manchester Management") acquired 300,000 units consisting of one share of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:15 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 300,000 | $6.00 | $1,800,000.00 |
DisclosureSEC source: 0000919574-22-001656 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 1,983,803 F1 · price: Manchester Management Company, LLC ("Manchester Management") acquired 300,000 units consisting of one share of Common Stock, par value $0.001 per share and one warrant to purchase one share of Common Stock, par value $0.001 per share. F2 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 11:05 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 2,497 | $7.51 Strike: $7.51 | $18,752.47 |
DisclosureSEC source: 0001019056-22-000008 · frank.xml · derivative · entry 2 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,497 Underlying: Common Stock · 2,497 shares Expires 2031-12-31 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 67,896 shares of the Issuer. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 11:05 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 9,987 | $7.51 Strike: $7.51 | $75,002.37 |
DisclosureSEC source: 0001019056-22-000008 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,987 Underlying: Common Stock · 9,987 shares Expires 2031-12-31 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 67,896 shares of the Issuer. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 17:29 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 6,292 | $2.98 Strike: $2.98 | $18,750.16 |
DisclosureSEC source: 0001019056-21-000521 · frank.xml · derivative · entry 2 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,292 Underlying: Common Stock · 6,292 shares Expires 2031-09-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 197,350 shares of the Issuer. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 17:29 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 25,168 | $2.98 Strike: $2.98 | $75,000.64 |
DisclosureSEC source: 0001019056-21-000521 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,168 Underlying: Common Stock · 25,168 shares Expires 2031-09-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 197,350 shares of the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:37 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 3,178 | $5.90 Strike: $5.90 | $18,750.20 |
DisclosureSEC source: 0001019056-21-000403 · frank.xml · derivative · entry 2 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,890 Underlying: Common Stock · 3,178 shares Expires 2031-06-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 165,890 shares of the Issuer. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:37 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 12,712 | $5.90 Strike: $5.90 | $75,000.80 |
DisclosureSEC source: 0001019056-21-000403 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,712 Underlying: Common Stock · 12,712 shares Expires 2031-06-30 F1 · security: The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date. F2 · balance_after: In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." As a result of the grants reported herein, the Reporting Person currently has aggregate options to purchase a total of 165,890 shares of the Issuer. Read SEC document |
| May 11, 2021 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantCommon Stock Pur-chase Warrant · Derivative | 379,174 | Not disclosed Strike: $2.87 | Not disclosed |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 8 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 379,174 Underlying: Common Stock, par value $0.001 per share · Not disclosed shares Expires 2027-02-06 F8 · price: The Common Stock Purchase Warrant (the "Warrant") entitles the holder of the warrant to shares of Common Stock equal to the principal amount of the Note divided by $2.87. The Warrants are not convertible until 271 days after the issue date. The foregoing description of the Warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Common Stock Purchase Warrant included as Exhibit 10.22 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F8 · derivative.underlying_shares: The Common Stock Purchase Warrant (the "Warrant") entitles the holder of the warrant to shares of Common Stock equal to the principal amount of the Note divided by $2.87. The Warrants are not convertible until 271 days after the issue date. The foregoing description of the Warrant does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Common Stock Purchase Warrant included as Exhibit 10.22 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 11, 2021 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantConvertible Promissory Note · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 7 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000,000 Underlying: Common Stock, par value $0.001 per share · Not disclosed shares Expires not disclosed F6 · derivative.exercise_price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · derivative.exercise_price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F6 · kind: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · kind: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F6 · price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F6 · derivative.exercise_date: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · derivative.exercise_date: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F6 · derivative.expiration_date: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F6 · derivative.underlying_shares: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · derivative.underlying_shares: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 11, 2021 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | Disposition to issuerConvertible Promissory Note · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 6 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 per share · Not disclosed shares Expires not disclosed F5 · derivative.exercise_price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F6 · kind: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · kind: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F6 · price: On May 11, 2021, the Note was converted into the May 2021 Convertible Promissory Note ("May Note"). The May Note is convertible upon (i) an offering of common stock or other securities ("Qualified Capital Raise") with total proceeds to the Issuer of not less than $12,000,000, or (ii) at any time following the day 271 days after the issue date. The May Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the sum of principal and accrued interest shall be multiplied by 1.25; e.g., $1,000 of principal which had accrued $60 of interest would be treated as if it were ($1,000 + $60) = $1,060 X 1.25 = $1,325 of capital invested in the Qualified Capital Raise for the purposes of determining the number of securities issued. F7 · price: (6 continued) The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 8-K filed on May 12, 2021, which is incorporated by reference. F5 · derivative.exercise_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · derivative.expiration_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · derivative.underlying_shares: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| February 08, 2021 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseConvertible Promissory Note · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · derivative · entry 5 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000,000 Underlying: Common Stock, par value $0.001 per share · Not disclosed shares Expires not disclosed F5 · derivative.exercise_price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · kind: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · price: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · derivative.exercise_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · derivative.expiration_date: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F5 · derivative.underlying_shares: On February 8, 2021, the Issuer completed an initial offering of the Convertible Promissory Note (the "Note"). The Note is convertible upon an equity financing with total proceeds to the Issuer of not less than $5,000,000. The Note is convertible into shares of Common Stock, par value $0.001 per share at a conversion price equal to the lowest cash price paid per share for equity securities by the investors in the equity financing multiplied by 0.80. The foregoing description of the Note does not purport to be complete and is subject to and qualified in its entirety by reference to the Form of Convertible Promissory Note included as Exhibit 10.21 of the Issuer's 10-Q filed on February 12, 2021, which is incorporated by reference. F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| November 30, 2020 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 34,843 | $2.87 | $99,999.41 |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 3 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,562 F3 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | FiEE, Inc. ZMTP · Entity 7395 | SaleCommon Stock, $0.01 par value | 142,857 | $1.95 | $278,571.15 |
DisclosureSEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 4 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · ownership.direct: The reported securities are directly owned by Morgan C. Frank in his personal capacity. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | FiEE, Inc. ZMTP · Entity 7395 | SaleCommon Stock, $0.01 par value | 143,357 | $1.95 | $279,546.15 |
DisclosureSEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 3 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | FiEE, Inc. ZMTP · Entity 7395 | SaleCommon Stock, $0.01 par value | 2,857,643 | $1.95 | $5,572,403.85 |
DisclosureSEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 2 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:05 UTC | FiEE, Inc. ZMTP · Entity 7395 | SaleCommon Stock, $0.01 par value | 4,287,214 | $1.95 | $8,360,067.30 |
DisclosureSEC source: 0000919574-20-004833 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · ownership.nature: Manchester Management Company, LLC, a Delaware limited liability company ("Manchester"), is principally engaged in the business of providing investment management services. The reported securities are indirectly beneficially owned by Manchester as a result of it having investment discretion over certain advisory accounts it manages, including Manchester Explorer, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of Manchester, and by Morgan C. Frank, who serves as a portfolio manager and as a consultant for Manchester. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 30, 2020 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 104,529 | $2.87 | $299,998.23 |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 2 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,022,105 F2 · ownership.nature: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 30, 2020 Filed Oct 29, 2021 22:43 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 34,843 | $2.87 | $99,999.41 |
DisclosureSEC source: 0000919574-21-006530 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner · Director by Deputization Manchester Explorer, L.P. · CIK 0001411524 · 10% owner · Director by Deputization MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner · Director by Deputization FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,051,409 F1 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 12, 2020 Filed May 19, 2020 17:03 UTC | Modular Medical, Inc. MODD · Entity 7488 | GrantOption to purchase common stock · Derivative | 150,000 | $2.87 Strike: $2.87 | $430,500.00 |
DisclosureSEC source: 0001019056-20-000351 · frank.xml · derivative · entry 1 FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-05-12 F1 · security: This option will vest as to one-third of the shares subject to the option on each annual anniversary of January 1, 2020. Read SEC document |
| November 20, 2018 Filed Nov 20, 2018 23:11 UTC | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 720,001 | $2.25 | $1,620,002.25 |
DisclosureSEC source: 0000919574-18-007647 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · ownership.direct: This Form 4 is being filed by Manchester Explorer, L.P. ("Explorer"), Manchester Management Company, LLC ("MMC"), James E. Besser and Morgan C. Frank as 10% Owners. MMC, provides investment management services to Explorer and other clients. The reported securities may be deemed indirectly beneficially owned by MMC as a result of it being the general partner of Explorer and such other clients. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as a Managing Member of MMC and by Morgan C. Frank, who serves as a portfolio manager and a consultant of MMC. Each of the Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act. F2 · ownership.direct: The reported 720,001 shares consists of (i) 471,112 shares purchased by Explorer, (ii) 160,000 shares purchased by another client of MMC, and (iii) 88,889 shares purchased by Mr. Besser. Read SEC document |
| November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 160,000 | $2.25 | $360,000.00 |
DisclosureSEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 4 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 917,576 F4 · ownership.nature: The reported securities are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 471,111 | $2.25 | $1,059,999.75 |
DisclosureSEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 3 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5,016,566 F3 · ownership.nature: The reported securities are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| November 20, 2018 Filed Oct 29, 2021 22:32 UTC Amendment | Modular Medical, Inc. MODD · Entity 7488 | PurchaseCommon Stock, par value $0.001 per share | 88,889 | $2.25 | $200,000.25 |
DisclosureSEC source: 0000919574-21-006529 · ownership.xml · nonDerivative · entry 1 MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,719 F1 · ownership.direct: The reported securities are directly owned by James E. Besser in his personal capacity. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 145,788 | $11.50 | $1,676,562.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 25 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 145,788 | $11.50 | $1,676,562.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 24 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,666,666 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 605 | $11.65 | $7,048.25 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 23 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,395,788 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 28, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 605 | $11.65 | $7,048.25 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 22 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,812,454 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 22,707 | $11.34 | $257,497.38 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 21 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,393 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 22,707 | $11.34 | $257,497.38 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 20 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,813,059 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 3,500 | $10.88 | $38,080.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 19 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,419,100 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 3,500 | $10.88 | $38,080.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 18 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,835,766 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 22, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 20,000 | $10.76 | $215,200.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 17 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422,600 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 22, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 20,000 | $10.76 | $215,200.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 16 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,839,266 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 21, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 210,311 | $10.18 | $2,140,965.98 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 15 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,442,600 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 21, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 210,311 | $10.18 | $2,140,965.98 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 14 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,859,266 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 20, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 15,183 | $9.70 | $147,275.10 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 13 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,652,911 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 20, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 15,183 | $9.70 | $147,275.10 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 12 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,069,577 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 20, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 4,200 | $9.54 | $40,068.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 11 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,668,094 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 20, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 4,200 | $9.54 | $40,068.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 10 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,084,760 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| March 19, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 200 | $9.57 | $1,914.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 9 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,672,294 F3 · ownership.direct: The reported securities are directly owned by Manchester Explorer, L.P., a Delaware limited partnership. Read SEC document |
| March 19, 2018 Filed Mar 29, 2018 21:10 UTC | FENNEC PHARMACEUTICALS INC. FENC · Entity 5601 | SaleCommon Stock | 200 | $9.57 | $1,914.00 |
DisclosureSEC source: 0000919574-18-002749 · p7852101_d.xml · nonDerivative · entry 8 MANCHESTER MANAGEMENT PR, LLC · CIK 0001735534 · 10% owner MANCHESTER MANAGEMENT CO LLC · CIK 0001169253 · 10% owner Manchester Explorer, L.P. · CIK 0001411524 · 10% owner BESSER JAMES E · CIK 0001512127 · 10% owner FRANK MORGAN C. · CIK 0001593072 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,088,960 F1 · ownership.nature: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions, including Manchester Explorer, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages and by Manchester Management Company, LLC as a result of it being the general partner over certain advisory accounts. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and as a Managing Member of Manchester Management Company, LLC, and by Morgan C. Frank, who serves as a portfolio manager and a consultant of Manchester Management Company, LLC. F2 · ownership.nature: Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.